The primary concern for most of the patients is the post-operative pain before initiating surgery. Around 80% of patients experience medium to extreme level of post-operative pain. Continuous peripheral nerve block catheter are proven to offer post-operative analgesia and improved satisfaction to patient when compared with opioids. The continuous peripheral nerve block catheter are used to perform nerve block procedure on patients for pain management. It is mainly available three basic types, stimulating catheter system, non-stimulating catheter system and over the needle catheter system.
According to Future Market Insights report, the global continuous peripheral nerve block catheter market was valued at US$ 411.0 Mn by the end of 2017 and expected to reach US$ 742.7 Mn by the end of 2027. The market is expected to register a CAGR of 6.1% during the forecast period.
What are the potential factors to surge demand for continuous peripheral nerve block catheter?
- Increasing incidence of chronic diseases like osteoarthritis
- Increasing demand in pain management and joint replacement operations
- Strong focus of market players on expansion of product portfolio
- Continuous product development and integration of innovative technologies
- Mergers and acquisition between major companies to diversify product portfolio and attract large customer base
- Increasing medical tourism worldwide
However, lack of awareness regarding standard guidelines to use continuous peripheral nerve block catheter coupled with lack of skilled professional for its placement are likely to hamper the sale of continuous peripheral nerve block catheter.
What is the future scenario for continuous peripheral nerve block catheter market?
The non-simulating catheter system is expected to account for maximum value share in the continuous peripheral nerve block catheter market. Increasing demand for non-stimulating catheter system for its comparatively high efficiency at low cost is expected to dominate the market during the forecast period. The sales of non-stimulating catheter system is estimated to account for US$ 430 Mn by the end of 2027 and expected to register a CAGR of 6.4%.
Practitioner uses continuous peripheral nerve block catheter in two different inserting techniques, ultrasound and nerve stimulation based inserting technique. Among these, device that uses ultrasound based insertion technique are expected to witness rise in demand in coming years. Increasing preference of practitioners on using ultrasound guidance over regional anesthesia and other techniques attributes to the market growth. Researcher are focusing to develop optimal scanning techniques for ultrasound based insertion in order to gain most accurate placement of tip to target plexus or nerve.
Where can continuous peripheral nerve block catheter manufacturers find potential opportunities for market expansion?
Continuous peripheral nerve catheter are widely used for several cases such as upper extremity surgeries, pain management, low extremity surgeries and other trauma cases. Among these, demand for continuous peripheral nerve block catheter in low extremity surgeries is expected to rise in the near future. Hospital are expected to account for major value share due to increasing rate of hospitalization in treatment of low extremity surgeries.
Developed regions like North America followed by Europe is expected to remain prevalent owing to increasing demand for continuous peripheral nerve block catheter in the near future. Introduction of innovative technologies in emerging economies of the Asia-Pacific excluding Japan (APEJ) and Middle East & Africa (MEA) in medical sector is expected to offer potential opportunities for market players during the forecast period. Major companies like B. Braun Melsungen AG, Epimed International Inc., Pajunk GmbH, Teleflex Incorporated and Halyard Health, Inc. are some of key stake holders operating in continuous peripheral nerve block catheter market
Request Report Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1307